Mobilized Leukopaks, G-CSF + Plerixafor, Fresh | StemExpress

Mobilized Leukopaks, G-CSF + Plerixafor, Fresh

In stock
Category: Research & Clinical Products
Select SKU Size / Day Price
MLE3PX4 Min x 3 Days - Apheresis Day 4 $45,875 USD
MLE4PX5 Min x 4 Days - Apheresis Day 5 $47,135 USD
MLE5PX6 Min x 5 Days - Apheresis Day 6 $49,089 USD
MLE3PX45 Min x 3 Days - Apheresis Day 4 & 5 $60,575 USD
MLE4PX56 Min x 4 Days - Apheresis Day 5 & 6 $64,050 USD
MLE5PX67 Min x 5 Days - Apheresis Day 6 & 7 $66,394 USD
Questions about shipping? See Shipping Info
Questions? Contact Sales:
Contact Us
Product Description

Human mobilized peripheral blood Leukopaks provide a rich source of hematopoietic stem cells as compared to traditional Leukopaks. This allows researchers greater reproducibility of experiments from a single donor (minimize donor-to-donor variation), increase in scalability of experiments from a single product, and a decrease in same cell variability by obtaining high yields of specific cell types.

Mobilized Leukopaks are collected from healthy IRB consented donors that are injected with a combination of 10µg/kg/day of Granulocyte-Colony Stimulating Factor (G-CSF) and 240µg/kg of Plerixafor the day before collection, which stimulates the bone marrow to produce hematopoietic stem cells and mobilizes them into the bloodstream, prior to first day of collection. Mobilized mononuclear cells are collected by a trained technician using the Spectra Optia® Apheresis System one and two days post injection. After collection, mobilized Leukopaks are checked by flow analysis to verify the percentage of granulocytes, mononuclear cells, CD34+ cells, and cell viability.

• 2x10e10 TNCs/1 bag
• Enriched PBMCs
• Enriched CD34+ cells
• Low hematocrit
• Low granulocytes

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.

Custom Orders

We work closely with our customers to provide them with the product they need. For a custom order, please call and speak to one of our sales specialists at 530-303-3828.

More Information
Species Human
Disease State Healthy
Cell and Tissue Source Peripheral Blood
Cell Type Mononuclear Cells
Donor Attributes Inquire
Viability ≥90% by Flow Cytometry
Format Fresh
Anticoagulant ACD-A
Size Minimum 20 billion TNCs/bag
Application Area Research
Injections 10μg/kg/day of G-CSF & 240μg/kg Plerixafor the day before collection

Product Information Sheet

Certificate of Analysis

Hi, have questions?

A StemExpress Expert is happy to help!

Got a Question?

Read our FAQs to answer your questions regarding the different types of donations, donor requirements, and our donation process.